MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS

This adverse event was reported 3 times

These drugs are most commonly taken by patients reporting MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS:

# Drug Count
0 ACETAMINOPHEN 1
1 ACETAMINOPHEN 500MG 1
2 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
3 CARBOPLATIN 1
4 NERATINIB 1
5 PAIN RELIEVER 1
See all common drugs associated with MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS

MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NERATINIB 1 0.0004
1 CARBOPLATIN 1 0.0000
2 ACETAMINOPHEN 1 0.0000
See all drugs enriched for association with MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS

These drug classes are most commonly taken by patients reporting MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS:

# Drug class Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 1
1 Platinum-based Drug [EPC] 1
See all common drug classes associated with MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS

MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Platinum-based Drug [EPC] 1 0.0000
1 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATOSIS